ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,970.84
      -1.11%
      US Tech 100
      20,897.20
      -1.35%
      Dow Jones
      42,992.21
      -0.77%
      Brent Oil
      73.44
      0.00%
      Bitcoin
      95,034.27
      -0.11%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Dyne Therapeutics Inc (DYN) Quote

      Dyne Therapeutics Inc

      Dyne Therapeutics Inc (DYN)

      NASDAQ
      23.72
      -0.75
      (-3.06%)
      Closed December 29 4:00PM
      Delayed by 15 minutes
      23.72
      0.01
      (0.04%)
      After Hours: 5:44PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      23.72
      Bid
      23.00
      Ask
      26.61
      Volume
      676,653
      23.40 Day's Range 24.88
      12.33 52 Week Range 47.45
      Market Cap
      2.414B
      Previous Close
      24.47
      Open
      24.20
      Last Trade
      437
      @
      23.72
      (formt)
      Last Trade Time
      Financial Volume
      $ 16,237,630
      VWAP
      23.997
      Average Volume (3m)
      900,388
      Shares Outstanding
      101,765,958
      Dividend Yield
      -
      PE Ratio
      -10.23
      Earnings Per Share (EPS)
      -2.32
      Revenue
      -
      Net Profit
      -235.94M

      About Dyne Therapeutics Inc

      Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.dyne-tx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Dyne Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DYN. The last closing price for Dyne Therapeutics was $24.47. Over the last year, Dyne Therapeutics shares have traded in a share price range of $ 12.33 to $ 47.45.

      Dyne Therapeutics currently has 101,765,958 shares outstanding. The market capitalization of Dyne Therapeutics is $2.49 billion. Dyne Therapeutics has a price to earnings ratio (PE ratio) of -10.23.

      Ask ADVFN Intelligence (AI)

      DYN Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      December 11 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      December 11 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 10 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 04 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 25 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 22 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 18 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.11-0.46160302140223.8324.923.3164488724.0370519CS
      4-7.125-23.099367806830.84531.2923.3174994926.65979246CS
      12-10.28-30.23529411763435.923.3190038829.75284201CS
      26-10.28-30.23529411763447.4523.31111351434.8082287CS
      5210.9585.747846515312.7747.4512.33140752828.26681025CS
      15610.8684.447900466612.8647.454.370615422.38502052CS
      2600.271.1513859275123.4547.454.357997821.81484544CS

      DYN - Frequently Asked Questions (FAQ)

      What is the current Dyne Therapeutics share price?
      The current share price of Dyne Therapeutics is $ 23.72
      How many Dyne Therapeutics shares are in issue?
      Dyne Therapeutics has 101,765,958 shares in issue
      What is the market cap of Dyne Therapeutics?
      The market capitalisation of Dyne Therapeutics is USD 2.49B
      What is the 1 year trading range for Dyne Therapeutics share price?
      Dyne Therapeutics has traded in the range of $ 12.33 to $ 47.45 during the past year
      What is the PE ratio of Dyne Therapeutics?
      The price to earnings ratio of Dyne Therapeutics is -10.23
      What is the reporting currency for Dyne Therapeutics?
      Dyne Therapeutics reports financial results in USD
      What is the latest annual profit for Dyne Therapeutics?
      The latest annual profit of Dyne Therapeutics is USD -235.94M
      What is the registered address of Dyne Therapeutics?
      The registered address for Dyne Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Dyne Therapeutics website address?
      The website address for Dyne Therapeutics is www.dyne-tx.com
      Which industry sector does Dyne Therapeutics operate in?
      Dyne Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      INTZIntrusion Inc
      $ 2.167
      (381.56%)
      		189.59M
      AILEiLearningEngines Inc
      $ 0.5932
      (267.31%)
      		563.26M
      HUBCWHub Cyber Security Ltd
      $ 0.035
      (250.00%)
      		2.79M
      GTIGraphjet Technology
      $ 0.967551
      (185.83%)
      		398.95M
      LITMSnow Lake Resources Ltd
      $ 1.61
      (82.95%)
      		131.98M
      NEUPNeuphoria Therapeutics Inc
      $ 4.11
      (-92.30%)
      		936.47k
      VIRXViracta Therapeutics Inc
      $ 0.16
      (-32.49%)
      		9.31M
      PRFXPainReform Ltd
      $ 3.48
      (-28.98%)
      		926.19k
      AIREreAlpha Tech Corporation
      $ 2.56
      (-28.49%)
      		8.26M
      AVGRAvinger Inc
      $ 0.9721
      (-24.05%)
      		2.11M
      AILEiLearningEngines Inc
      $ 0.5932
      (267.31%)
      		563.26M
      GTIGraphjet Technology
      $ 0.967551
      (185.83%)
      		398.95M
      RGTIRigetti Computing Inc
      $ 17.08
      (10.62%)
      		305.79M
      XTIAXTI Aerospace Inc
      $ 0.03935
      (-1.63%)
      		268M
      QSIQuantum Si Inc
      $ 3.585
      (66.74%)
      		256.01M

      Discussion

      View Full Feed
      Investor2014 Investor2014 13 minutes ago
      This is the 15 minutes ADPD presentation.

      The programme for the JPM conference will be published soon.
      JPM
      LTR LTR 25 minutes ago
      I am extremely bullish but I said 0.61 only because I believe there will be another strong co-ordinated attack on the stock. These MM's have not acquiesced in the on going face of the lawsuit. Their naked short position may prevent them from ever changing that position, though its clear their effo
      NWBO
      Tennispro Tennispro 26 minutes ago
      Thanks for the update, much appreciated!

      $RNVA$ Lets go!!!
      RNVA
      quester614 quester614 27 minutes ago
      WRONG the first case was thrown out because the Plaintiff FAILED to defend the sufficiency of the STATE law claims (JURISDICTION) of another State which therefore DISAMISSED. This is exactly what the appellate court will REVIEW.
      So after Onyuwoma Williams Igbokwe supplied the written brief D
      XERI
      Nextbigone Nextbigone 1 hour ago
      style="white-space: pre-wrap; caret-color: rgb(27, 26, 24); color: rgba(27, 26, 24, 1); font-family: Nib, sans-serif; font-size: 30px; font-weight: 600; background-color: rgba(255, 255, 255, 1)"Metalpha (NASDAQ:MATH) – the only listed APAC, undiscovered crypto exotic derivative broker microcap pure-
      MATH
      mascale mascale 1 hour ago
      Global opinion of Tasmania--Google AI: "Yes, Tasmania is considered one of the most highly mineralized areas in the world, with a diverse range of mineral deposits including tin, zinc, iron ore, and precious metals, making it a significant mining region despite its relatively small size."
      HIRU
      flipper44 flipper44 1 hour ago
      Here are some simple questions. Viewing the two filings on December 26, how much did/will NWBO receive prior to January 1, and how much in addition to that before February 1, and what is the monthly burn rate, and what did NWBO already owe by December 26?
      NWBO
      mascale mascale 1 hour ago
      Hiru itself is recently now locally connected in Tasmania, from a basis with likely connections to Qatar-based experience and connections. That part has so far not been widely noted. There is considerable international mining expertise, Qatar connected.
      HIRU
      flipper44 flipper44 2 hours ago
      Ex has always said, for years, 99% chance it will not be approved. His goal since he got here is to convince people it won’t. One of his backup profiles, investor082, covers a different angle. He states there will be approval but no financing.
      NWBO
      GrantHorvat1 GrantHorvat1 2 hours ago
      "Chart is a disaster"

      Tells me all I need to know ffs lol...

      Not that I didn't know it already about you...

      Youre a WEIRDO...

      GVSI
      SkeBallLarry SkeBallLarry 2 hours ago
      At least 124 dead after plane crashes >

      while landing in South Korea
      https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
      SkeBallLarry SkeBallLarry 2 hours ago
      At least 124 dead after plane crashes >

      while landing in South Korea
      https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
      Phoenix2020 Phoenix2020 2 hours ago
      Friday's daily short sale volume was 74.61% (as reported by FINRA) and it seems that the shorts are trying hard to manipulate the market! The short borrow fee is 12.87% and the shorts have increased their position by another 600'000 shares to 6.14 million shares that are currently shorted. It should
      CVM
      SkeBallLarry SkeBallLarry 2 hours ago
      At least 124 dead after plane crashes >

      while landing in South Korea
      https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
      SkeBallLarry SkeBallLarry 2 hours ago
      At least 124 dead after plane crashes >

      while landing in South Korea
      https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
      cowtown jay cowtown jay 2 hours ago
      Here's a partial transcript of a discussion between Dr. John Campbell and Dr. Angus Dalgleish regarding a drug similar to lenz.

      "21:17
      we've done the phase one phase two is does it work every single phase two study we've done it clearly is of
      21:23
      benefit phase t
      SkeBallLarry SkeBallLarry 2 hours ago
      At least 124 dead after plane crashes >

      while landing in South Korea
      https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
      Nrdc92 Nrdc92 2 hours ago
      Written like someone who doesn't have a clue, Jeunke. Beyond the rampant speculation in your post, it is ludicrous to believe that LWLG is in Tier 1 negotiations. No company during critical, major negotiations jettisons a respected  scientist and the company's CEO without a meaningful public explana
      LWLG
      Alexulf Alexulf 2 hours ago
      Steve Reinharz: A Visionary Leader in AI and Security Innovation


      Steve Reinharz, the CEO and CTO of Artificial Intelligence Technology Solutions (AITX), is a true visionary in the field of AI and security innovation. His passion for developing AI-powered, autonomous security s
      AITX
      Iggy_Bot Iggy_Bot 2 hours ago
      If i can answer for Kash, the answer would be Nothing as usual. feckless
      FireMechanic FireMechanic 2 hours ago
      Tne dow isn't 43,000 and Bitcoin isn't 100K!!! The current administration is working with the right people to keep these numbers. Unfortunately they will drop this in trump administration lap and say it's his fault. Gonna be millions of people in the world hurting soon mostly because of our crooked
      BTCUSD
      theswordman theswordman 2 hours ago
      💯
      CKPT
      janetcanada janetcanada 2 hours ago
      ***I have been reading this in the past???....

      1️⃣ 5 cents. Nickel.
      2️⃣10 cents. Dime.
      3️⃣ 25 cents Quarter.
      4️⃣1 dollar.
      RDAR
      theswordman theswordman 2 hours ago
      The official answer is at clinical trials . gov.

      Trial NCT06699836

      It is a PH II with est start FEB 2025

      est finish JUN 2028

      60 patients. Last update 21 NOV 2024

      This is an open label, randomized, two arm, multi-center study
      MSS
      123tom 123tom 3 hours ago
      Looking at the chart, I'm thinking first the 10 to 9 area, in the next wave down. It would look discouraging to see a great rally from 8.50 to 14.50 fall all the way back down... that wouldn't feel like how a good news rally should be. I'd be ok to watch it hold at 10-11 and begin the next surge
      AVXL

      Your Recent History

      NASDAQ
      DYN
      Dyne Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads